S-oxidation of S-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomes

References

• CASHMAN, J. R., 1995, Structural and catalytic properties of the mammalian fiavin-containing monooxygenase. Chemical Research in Toxicology, 8, 166–181.
   PubMed Web of Science ®Google Scholar
• DAMANI, L. A. and NNANE, I. P., 1996, The assessment of fiavin-containing monooxygenase activity in intact animals. Drug Metabolism and Drug Interactions, 13, 1–28.
   PubMedGoogle Scholar
• DOLPHIN, C. T., CULLINGFORD, T. E., SHEPHARD, E. A., SMITH, R. L. and PHILLIPS, I. R., 1996, Differential development and tissue-specific regulation of expression of the genes encoding three members of the fiavin containing monooxygenase family of man, FM01, FM03 and FM04. European Journal of Biochemistry, 235, 683–689.
   PubMedGoogle Scholar
• GIANCARLO, G. M., VENKATAKRISHNAN, K., GRANDA, B. W., VON MOLTKE, L. L. and GREENBLATT, D. J., 2001, Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. European Journal of Clinical Pharmacology, 57, 31–36.
   PubMed Web of Science ®Google Scholar
• KAMEO, K., OGAWA, K., TAKESHITA, K., NAKAIKE, S., TOMISAWA, K. and SOTA, K., 1988, Studies on antirheumatic agents: 3-benzoylpropionic acid derivatives. Chemical and Pharmacology Bulletin (Tokyo), 36, 2050–2060.
   PubMed Web of Science ®Google Scholar
• KORZEKWA, K. R., KRISHNAMACHARY, N., SHOU, M., OGAI, A., PARISE, R. A., RETTIE, A. E., GONZALEZ, F. J. and TRACY, T. S., 1998, Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry, 37, 4137–4147.
   PubMed Web of Science ®Google Scholar
• LANG, D. H. and RETTIE, A. E., 2000, In vitro evaluation of potential in vivo probes for human fiavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. British Journal of Clinical Pharmacology, 50, 311–314.
   PubMed Web of Science ®Google Scholar
• LAWTON, M. P., CASHMAN, J. R., CRESTEIL, T., DOLPHIN, C. T., ELFARRA, A. A., HINES, R. N., HODGSON, E., KIMURA, T., OZOLS, J., PHILLIPS, I. R., PHILPOT, R. M., POULSEN, L. L., RETTE, A. E., SHEPHARD, E. A., WILLIAMS, D. E. and ZIEGLER, D. M., 1994, A nomenclature for the mammalian fiavin-containing monooxygenase gene family based on amino acid sequence identities. Archives of Biochemistry and Biophysics, 308, 254–257.
   PubMed Web of Science ®Google Scholar
• LOMRI, N., Gu, Q. and CASHMAN, J. R., 1995, Molecular cloning of the fiavin-containing monooxygenase (form II) cDNA from adult human liver. Proceedings of the National Academy of Sciences, USA, 92, 9910.
   PubMed Web of Science ®Google Scholar
• OVERBY, L. H., CARVER, G. C. and PHILPOT, R. M., 1997, Quantitation and kinetic properties of hepatic microsomal and recombinant fiavin-containing monooxygenases 3 and 5 from humans. Chemico-Biological Interactions, 106, 29–45.
   PubMed Web of Science ®Google Scholar
• PHILLIPS, I. R., DOLPHIN, C. T., CLAIR, P., HADLEY, M. R., HUTT, A. J., McCommE, R. R., SMITH, R. L. and SHEPHARD, E. A., 1995, The molecular biology of the fiavin-containing monooxygenases of man. Chemico-Biological Interactions, 96, 17–32.
   PubMed Web of Science ®Google Scholar
• SADEQUE, A. J. M., THUMMEL, K. E. and RETTIE, A. E., 1993, Purification of macaque liver fiavin-containing monooxygenase: A form of the enzyme related immunochemically to an isozyme expressed selectively in adult human liver. Biochimica et Biophysica Acta, 1162, 127–134.
   Google Scholar
• SAKANE, T., SUZUKI, N., HIROSE, Y., MIURA, K., WAKISAKA, S., NAGAFUCHI, H., IcHINT°, M., TOMITA, T., HASHIMOTO, H., Oulu, T. and MIHARA, S., 1997, Mechanisms of KE-298, 2-acetylthiomethy1-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis. Journal of Rheumatology, 24, 2213–2220.
   Google Scholar
• SHAH, V. P., MIDHA, K. K., DIGHE, S., MCGILVERAY, I. J., SKELLY, J. P., YACOBI, A., LAYLOFF, T., VISWANATHAN, C. T., COOK, C. E., MCDOWALL, R. D., PITTMAN, K. A. and SPECTOR, S., 1992), Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Journal of Pharmacological Sciences, 81, 309–312.
   Web of Science ®Google Scholar
• TAKAHASHI, S., INOUE, T., HIGAKI, M. and MIZUSHIMA, Y., 1998, Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes. Drugs in Experimental and Clinical Research, 24, 67–71.
   PubMedGoogle Scholar
• VENKATAKRISHNAN, K., VON MOLTKE, L. L. and GREENBLATT, D. J., 2001, Human drug metabolism and the cytochromes P450: application and relevance of in vitro models. Journal of Clinical Pharmacology, 41, 1149–1179.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI, J., OHMICHI, M., HASEGAWA, M., YOSHIDA, H., OGAWA, N. and HIGUCHI, S., 2001, Identification of rat urinary and biliary metabolites of Esonarimod, a novel antirheumatic drug, using liquid chromatography/electrospray ionization tandem mass spectrometry with postcolumn addition of 2-(2-methoxyethoxy)ethanol, a signal-enhancing modifier. Drug Metabolism and Disposition, 29, 806–812.
   PubMed Web of Science ®Google Scholar
• YEUNG, C. K., LANG, D. H., THUMMEL, K. E. and RETTIE, A. E., 2000, Immunoquantitation of FM01 in human liver, kidney and intestine. Drug Metabolism and Disposition, 28, 1107–1111.
   PubMed Web of Science ®Google Scholar
• YOSHIDA, H., KOHNO, Y., ENDO, H., HASEGAWA, M., YAMAGUCHI, J., TOMISAWA, K. and SUWA, T., 1996, Identification of metabolites of KE-298, a new antirheumatic drug, and its physiological properties in rats. Biological and Pharmaceutical Bulletin, 19, 424–429.
   PubMed Web of Science ®Google Scholar
• ZIEGLER, D. M., 1993, Recent studies on the structure and function of multisubstrate fiavin-containing monooxygenases. Annual Reviews in Pharmacology and Toxicology, 33, 179–199.
   PubMed Web of Science ®Google Scholar